Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI2 | P48307 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | PPM1B | O75688 | 3/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | PPP1CC | P36873 | 3/20 | 0.68 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.59 |
| ▸ | PPP5C | P53041 | 2/20 | 0.57 |
| ▸ | PPP2CA | P67775 | 1/20 | 0.57 |
| ▸ | NPY4R | P50391 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Endothall SCHEMBL9464699 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL3495744 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL11394413 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL55158 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL8536404 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL9464559 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL13480837 | 1.00 | TFPI2 (1.00) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL11143562 | 0.97 | TFPI2 (0.94) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL29512510 | 0.97 | TFPI2 (0.94) | TFPI2LMNAKDM4EGMNNPMP22 | |
| Endothall SCHEMBL14861262 | 0.97 | TFPI2 (0.94) | TFPI2LMNAKDM4EGMNNPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2086534-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | Genetic Technologies Limited (AU) | 2009-08-12 | — | — | EP | claimed |
| WO-2008058342-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2008-05-22 | — | — | WO | claimed |
| CN-114845553-A | Method for weed growth control | 马斯特格罗生物制品公司 | 2022-08-02 | — | — | CN | disclosed |
| US-10399993-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | LIXTE BIOTECHNOLOGY, INC. (US) | 2019-09-03 | — | — | US | disclosed |
| US-10023587-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | LIXTE BIOTECHNOLOGY, INC. (US) | 2018-07-17 | — | — | US | disclosed |
| US-10023587-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | LIXTE BIOTECHNOLOGY, INC. (US) | 2018-07-17 | — | — | US | disclosed |
| US-20170369503-A1 | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE | LIXTE BIOTECHNOLOGY, INC. (US) | 2017-12-28 | — | — | US | disclosed |
| EP-2124550-B1 | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE | LIXTE BIOTECHNOLOGY INC (US) | 2017-04-19 | — | — | EP | disclosed |
| US-9079917-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | LIXTE BIOTECHNOLOGY, INC. (US) | 2015-07-14 | — | — | US | disclosed |
| US-9079917-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | LIXTE BIOTECHNOLOGY, INC. (US) | 2015-07-14 | — | — | US | disclosed |
| US-20150045373-A1 | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE | LIXTE BIOTECHNOLOGY, INC. | 2015-02-12 | — | — | US | disclosed |
| US-5241104-A | Reacting acid anhydride with arylacetic acid derivatives; for preparing optically active prostaglandins | SHIONOGI & CO., LTD. (JP) | 1993-08-31 | — | — | US | disclosed |
| EP-0373949-B1 | MONO ESTERS OF DICARBOXYLIC ACIDS, THEIR PREPARATION AND USE | SHIONOGI & CO (JP) | 1993-08-25 | — | — | EP | disclosed |
| EP-0373931-B1 | MONOESTERS OF ARYLACETIC ACID, THEIR PRODUCTION AND USE | SHIONOGI & CO (JP) | 1993-07-28 | — | — | EP | disclosed |
| US-5183909-A | Useful as intermediate for production of prostaglandins, terpenes, aminosugars, nucleotides and alkaloids | SHIONOGI & COMPANY, LTD. (JP) | 1993-02-02 | — | — | US | disclosed |
| US-5175341-A | Bicyclo 2.2.2!heptanedicarboxylic acid derivatives | SHIONOGI & CO., LTD. (JP) | 1992-12-29 | — | — | US | disclosed |
| US-5117039-A | Intermediates for Prostaglandin Preparation | SHIONOGI & CO., LTD. (JP) | 1992-05-26 | — | — | US | disclosed |
| US-5047574-A | CHEMICAL INTERMEDIATES FOR OPTICALLY ACTIVE PRODUCTS, MEDICINES | SHIONOGI & CO., LTD. (JP) | 1991-09-10 | — | — | US | disclosed |
| EP-0373931-A2 | Monoesters of arylacetic acid, their production and use | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1990-06-20 | — | — | EP | disclosed |
| EP-0373949-A1 | Mono esters of dicarboxylic acids, their preparation and use | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) | 1990-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045373-A1 | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE | HCCS, OXA1L, OTC | TFPI2 4858/4885LMNA 2628/4885KDM4E 1204/4885 |
| US-10399993-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | HCCS, OXA1L, OTC | TFPI2 4858/4885LMNA 2628/4885KDM4E 1204/4885 |
| US-20170369503-A1 | OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE | HCCS, OXA1L, OTC | TFPI2 4858/4885LMNA 2628/4885KDM4E 1204/4885 |
| US-10023587-B2 | Oxabicycloheptanes and oxabicycloheptenes, their preparation and use | HCCS, OXA1L, OTC | TFPI2 4858/4885LMNA 2628/4885KDM4E 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.